Detalhe da pesquisa
1.
Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis.
J Pathol
; 257(1): 82-95, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35064579
2.
Extracellular Signal-Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma Cells.
Hepatology
; 74(4): 2007-2020, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33959996
3.
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma.
J Hepatol
; 74(6): 1373-1385, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33484774
4.
MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease.
J Hepatol
; 64(3): 682-90, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26596542
5.
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma.
Gut
; 64(9): 1454-65, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25183205
6.
Role of a Novel Silver Fir (Abies alba) Extract, Abigenol®/AlbiPhenol®, in Modulating Cardiovascular Disorders: Key Factors.
Antioxidants (Basel)
; 11(4)2022 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35453303
7.
Intestinal Absorption Study of a Granular Form of Ferric Pyrophosphate.
Metabolites
; 12(5)2022 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35629967
8.
Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators.
JHEP Rep
; 4(4): 100444, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35252828
9.
Dephosphorylation and inactivation of Akt/PKB is counteracted by protein kinase CK2 in HEK 293T cells.
Cell Mol Life Sci
; 66(20): 3363-73, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19662498
10.
Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
Biochem J
; 421(3): 387-95, 2009 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19432557
11.
Role of Chemokines in the Biology of Cholangiocarcinoma.
Cancers (Basel)
; 12(8)2020 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32784743
12.
Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives.
Cells
; 9(3)2020 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32138158
13.
The selectivity of inhibitors of protein kinase CK2: an update.
Biochem J
; 415(3): 353-65, 2008 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18588507
14.
Myostatin regulates the fibrogenic phenotype of hepatic stellate cells via c-jun N-terminal kinase activation.
Dig Liver Dis
; 51(10): 1400-1408, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31005555
15.
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells.
Oncogenesis
; 8(11): 61, 2019 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31641101
16.
Liver fibrosis in the context of nonalcoholic steatohepatitis: the role of adipokines.
Minerva Gastroenterol Dietol
; 64(1): 39-50, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28875689
17.
Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response.
Clin Cancer Res
; 18(7): 1888-900, 2012 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22351691
18.
Assessment of CK2 constitutive activity in cancer cells.
Methods Enzymol
; 484: 495-514, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21036247
19.
Comparative analysis of CK2 expression and function in tumor cell lines displaying sensitivity vs. resistance to chemical induced apoptosis.
Mol Cell Biochem
; 316(1-2): 155-61, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18560764
20.
Heterogeneity of CK2 phosphorylation sites in the NS5A protein of different hepatitis C virus genotypes.
J Hepatol
; 47(6): 768-76, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17923166